UNC Oncology Clinical Translational Research Training Program

北卡罗来纳大学肿瘤学临床转化研究培训计划

基本信息

  • 批准号:
    8128673
  • 负责人:
  • 金额:
    $ 26.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-17 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In this revised submission, the University of North Carolina at Chapel Hill (UNC) Divisions of Adult and Pediatric Hematology/Oncology, the Department of Radiation Oncology, the UNC Lineberger Comprehensive Cancer Center (UNC-LCCC) and the Division of Gastroenterology and Hepatology propose to create the UNC Oncology Clinical/Translational Research Training Program (OCT-RTP). All four of the components will contribute mentors and research resources to the proposed training program, and all components except UNC-LCCC will contribute scholars. OCT-RTP will admit two scholars per year. Thus, in Year One, the Program will sponsor two scholars. In Years Two - Five, the Program will sponsor four scholars (two new, two continuing). The PI, Dr. Richard Goldberg, is Professor and Chief of Hematology/Oncology and UNC-LCCC Associate Director for Clinical Research and has extensive experience in the direction, planning, and execution of oncology clinical trials. The program's objectives are to establish a highly motivated and rigorously trained cadre of physician clinical researchers who are competitive in seeking research support and who will become successful, independent patient-oriented cancer investigators. Training resources that will be available for the OCT-RTP include: the Lineberger Comprehensive Cancer Center, the North Carolina Cancer Hospital, the UNC School of Medicine K30 Clinical Research Curriculum and the UNC Program on Ethnicity Culture and Health Outcomes. X The goals of the OCT-RTP are to increase the quality and quantity of patient-oriented research, including all phases of clinical research and particularly that involving a translational component. The foundation of the proposed training program will be the participation of highly qualified basic science and clinical mentors assigned to each scholar with mentoring activities coordinated by a mentor integration panel. An internal advisory committee that includes senior faculty from each of the four components will select and monitor the progress of scholars, while an external advisory committee will review the program annually.
描述(由申请人提供):在此修订后的提交中,成人和小儿血液学/小儿血液学/肿瘤学的北卡罗来纳大学分裂,放射线肿瘤学系,UNC Lineberger综合癌症中心(UNC-LCCC)和胃病学和肝病学秘诀,以创建INF术语/翻译培训计划(INF)训练(创建INF术语/翻译计划)这四个组件将为拟议的培训计划贡献导师和研究资源,除UNC-LCCC以外的所有组件都将贡献学者。 OCT-RTP每年将接受两名学者。因此,在第一年,该计划将赞助两位学者。在二年级 - 五年中,该计划将赞助四个学者(两名新学者,两个继续)。 PI Richard Goldberg博士是血液学/肿瘤学教授兼临床研究副总监,并在肿瘤学临床试验的方向,计划和执行方面具有丰富的经验。该计划的目标是建立一个有积极进取和严格训练的医师临床研究人员的干部,他们在寻求研究支持并将成为成功的,独立的患者癌症研究人员方面具有竞争力。将为OCT-RTP提供的培训资源包括:Lineberger综合癌症中心,北卡罗来纳州癌症医院,UNC医学学院K30临床研究课程以及有关种族文化和健康成果的UNC计划。 x OCT-RTP的目标是提高面向患者的研究的质量和数量,包括临床研究的所有阶段,尤其是涉及转化成分的阶段。拟议的培训计划的基础将是由高素质的基础科学和临床指导者的参与,并通过指导的指导活动由导师一体化小组协调。包括来自四个组成部分的每个组成部分的高级教师在内的内部咨询委员会将选择和监视学者的进度,而外部咨询委员会将每年审查该计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NORMAN E SHARPLESS其他文献

NORMAN E SHARPLESS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NORMAN E SHARPLESS', 18)}}的其他基金

In vivo murine models of metastasis for therapeutic testing
用于治疗测试的体内转移小鼠模型
  • 批准号:
    8221401
  • 财政年份:
    2012
  • 资助金额:
    $ 26.8万
  • 项目类别:
In vivo murine models of metastasis for therapeutic testing
用于治疗测试的体内转移小鼠模型
  • 批准号:
    8628801
  • 财政年份:
    2012
  • 资助金额:
    $ 26.8万
  • 项目类别:
In vivo murine models of metastasis for therapeutic testing
用于治疗测试的体内转移小鼠模型
  • 批准号:
    9038322
  • 财政年份:
    2012
  • 资助金额:
    $ 26.8万
  • 项目类别:
In vivo murine models of metastasis for therapeutic testing
用于治疗测试的体内转移小鼠模型
  • 批准号:
    8459980
  • 财政年份:
    2012
  • 资助金额:
    $ 26.8万
  • 项目类别:
In vivo murine models of metastasis for therapeutic testing
用于治疗测试的体内转移小鼠模型
  • 批准号:
    8827705
  • 财政年份:
    2012
  • 资助金额:
    $ 26.8万
  • 项目类别:
UNC Oncology Clinical Translational Research Training Program
北卡罗来纳大学肿瘤学临床转化研究培训计划
  • 批准号:
    8279948
  • 财政年份:
    2007
  • 资助金额:
    $ 26.8万
  • 项目类别:
UNC Oncology Clinical Translational Research Training Program
北卡罗来纳大学肿瘤学临床转化研究培训计划
  • 批准号:
    8733436
  • 财政年份:
    2007
  • 资助金额:
    $ 26.8万
  • 项目类别:
UNC Oncology Clinical Translational Research Training Program
北卡罗来纳大学肿瘤学临床转化研究培训计划
  • 批准号:
    8549118
  • 财政年份:
    2007
  • 资助金额:
    $ 26.8万
  • 项目类别:
Murine & Human In Vivo Models of Melanoma Formation
鼠类
  • 批准号:
    7246102
  • 财政年份:
    2007
  • 资助金额:
    $ 26.8万
  • 项目类别:
UNC Oncology Clinical Translational Research Training Program
北卡罗来纳大学肿瘤学临床转化研究培训计划
  • 批准号:
    8921117
  • 财政年份:
    2007
  • 资助金额:
    $ 26.8万
  • 项目类别:

相似海外基金

Elucidating the role of DCAF7 on hematopoietic stem cell maintenance
阐明 DCAF7 对造血干细胞维持的作用
  • 批准号:
    10785443
  • 财政年份:
    2023
  • 资助金额:
    $ 26.8万
  • 项目类别:
Implications of Prefrontal Cortex Development for Adolescent Reward Seeking Behavior
前额皮质发育对青少年奖励寻求行为的影响
  • 批准号:
    10739548
  • 财政年份:
    2023
  • 资助金额:
    $ 26.8万
  • 项目类别:
Expanding Multilevel Multicomponent Mentorship in Kidney Disease Research
扩大肾脏疾病研究中的多层次多成分指导
  • 批准号:
    10797774
  • 财政年份:
    2023
  • 资助金额:
    $ 26.8万
  • 项目类别:
Support Mentoring of Early Career Clinical Researchers from Diverse Backgrounds
支持来自不同背景的早期职业临床研究人员的指导
  • 批准号:
    10797859
  • 财政年份:
    2023
  • 资助金额:
    $ 26.8万
  • 项目类别:
The Single Cell Landscape of Early Human Diabetic Nephropathy
早期人类糖尿病肾病的单细胞景观
  • 批准号:
    10765844
  • 财政年份:
    2023
  • 资助金额:
    $ 26.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了